Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Recursion Pharmaceuticals Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Recursion Pharmaceuticals Inc tiene un total de activos de $1,448, una ganancia neta loss de $-463

Question 2

¿Cuáles son los ratios financieros clave para RXRX?

Accepted Answer

El ratio corriente de Recursion Pharmaceuticals Inc es 3.5, el margen neto es -798.27, las ventas por acción son $0.21.

Question 3

¿Cómo se desglosan los ingresos de Recursion Pharmaceuticals Inc por segmento o geografía?

Accepted Answer

Recursion Pharmaceuticals Inc largest revenue segment is Drug Discovery, at a revenue of 58,839,000 in the most earnings release.For geography, United States is the primary market for Recursion Pharmaceuticals Inc, at a revenue of 58,839,000.

Question 4

¿Es rentable Recursion Pharmaceuticals Inc?

Accepted Answer

no, según los últimos estados financieros, Recursion Pharmaceuticals Inc tiene una ganancia neta loss de $-463

Question 5

¿Tiene Recursion Pharmaceuticals Inc alguna deuda?

Accepted Answer

yes, Recursion Pharmaceuticals Inc tiene una deuda de 413

Question 6

¿Cuántas acciones en circulación tiene Recursion Pharmaceuticals Inc?

Accepted Answer

Recursion Pharmaceuticals Inc tiene un total de acciones en circulación de 396.5

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	43	58	44	39	10	3
Revenue Growth (YoY)	-34%	32%	13%	290%	233%	50%
Cost of Revenue	69	45	42	48	--	--
Gross Profit	-25	13	1	-8	--	--
Selling, General & Admin	220	178	133	95	66	27
Research & Development	470	295	208	141	125	61
Operating Expenses	697	492	350	237	192	88
Other Non Operating Income (Expenses)	-1	0	-1	0	0	0
Pretax Income	-715	-464	-332	-239	-186	-87
Income Tax Expense	0	-1	-4	--	--	--
Net Income	-715	-463	-328	-239	-186	-87
Net Income Growth	90%	41%	37%	28%	113.99%	43%
Shares Outstanding (Diluted)	446.98	274.2	207.85	175.54	125.35	162.16
Shares Change (YoY)	57.99%	32%	18%	40%	-23%	0%
EPS (Diluted)	-1.6	-1.69	-1.57	-1.36	-1.49	-0.54
EPS Growth	20%	7%	16%	-9%	176%	42%
Free Cash Flow	-447	-372	-299	-120	-198	-51
Free Cash Flow Per Share	-1	-1.35	-1.43	-0.68	-1.57	-0.31
Gross Margin	-58.13%	22.41%	2.27%	-20.51%	--	--
Operating Margin	-1,681.39%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Profit Margin	-1,662.79%	-798.27%	-745.45%	-612.82%	-1,860%	-2,900%
Free Cash Flow Margin	-1,039.53%	-641.37%	-679.54%	-307.69%	-1,980%	-1,700%
EBITDA	-646	-461	-340	-245	-182	-80
EBITDA Margin	-1,502.32%	-794.82%	-772.72%	-628.2%	-1,820%	-2,666.66%
D&A For EBITDA	77	18	8	0	0	4
EBIT	-723	-479	-348	-245	-182	-84
EBIT Margin	-1,681.39%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Effective Tax Rate	0%	0.21%	1.2%	--	--	--

Recursion Pharmaceuticals Inc (RXRX) Price

RXRX Stock Price Chart

RXRX Income

Follow-Up Questions